As the first generation of Alzheimer's disease drugs hits the market, some researchers are troubled by the lack of clinical data available on the effectiveness of these drugs in Black people. ...
Experts share why protection by the exclusion of pregnant people leads to a lack of evidence-based medicine and ways to improve clinical trial conduct....
Increased diversity in clinical trials should be a requirement, not a suggestion....
The pre-pandemic environment for clinical trials has been described as unsustainable by many observers, so the massive disruption caused by COVID-19 also presents ripe opportunities for improvement....
The need for more diversity in clinical trials is being increasingly emphasized, but more creative and collaborative recruitment approaches may be needed to make trials more diverse....
Achieving clinical trial diversity will require a multi-stakeholder approach across the healthcare ecosystem, including efforts by government agencies, health systems, and industry....
The Food and Drug Administration has approved Sunlenca, an injectable therapy to suppress HIV for patients who suffered drug resistance to other regimens....
While the use of digital health technologies has increased in clinical trials, securing patients' trust continues to be a significant challenge. These technologies may help build trust by helping to increase representation in clinical trials....
The global life sciences industry has much to learn to bridge the diversity divide in cancer clinical trial participation. The good news is advanced technology can help—it’s time to leverage such modern innovations as artificial intelligence (AI), digital tools, and analytics software to move the...
Research programs and studies that are built on a DEI foundation will inevitably have a positive influence on the trajectory of goals that include increasing diversity in clinical trials and cultivating inclusive environments for the biomedical research workforce....
